Open-Label Tolvaptan Study in Subjects With ADPKD (TEMPO 4/4)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01214421
Recruitment Status : Completed
First Posted : October 5, 2010
Last Update Posted : May 25, 2018
Information provided by (Responsible Party):
Otsuka Pharmaceutical Development & Commercialization, Inc.